The glycolytic rate was determined using an XF Glycolytic Rate Assay Kit (Agilent, Santa Clara, CA, USA) with final concentrations of 0.5 M rotenone/antimycin A (Rot/AA) and 50 mM 2-deoxy glucose (2-DG) sequentially injected into the SM media
The 2022 ASMBS/IFSO guidelines state that metabolic and bariatric surgery has extensive evidence for safety, efficacy, and durability, with overall long-term outcomes often exceeding 60% excess weight loss
J Clin Endocrinol Metab , 1990;70(4):97582
Continence Reports, 100083
This section compiles key research citations that have informed the discussions throughout this article, offering a resource for further reading and exploration
doi: 10.3233/JPD-171068 201 VertesR